The rise of Sildenafil initially drove a period of growth for major pharmaceutical companies, but recent changes present a complicated outlook for those considering a stake. Generic versions are eating into revenue, https://tiannajcnx166547.jts-blog.com/39808914/sildenafil-and-big-pharma-a-precarious-investment